NCT01760655 arm group cd39c7e245762b84be1f2743b196e5c5 [clinicaltrials_resource:NCT01760655/arm-group/cd39c7e245762b84be1f2743b196e5c5]
Total body irradiation [clinicaltrials_resource:0f8152df7abbc89f902585ccb131130f]Mycophenolate mofetil [clinicaltrials_resource:359b03f10f52dde58e341752c97a94f8]Cyclophosphamide [clinicaltrials_resource:47388bb0cf9b94c4b408702cd70ee15f]Therapeutic allogeneic lymphocytes [clinicaltrials_resource:5107d2b2805a4abee0edbb9df278a396]Tacrolimus [clinicaltrials_resource:74783454cbb1a74d88d96fcad8b0c37b]Peripheral blood stem cell transplantation [clinicaltrials_resource:94060a86c5a74ebc54f36f4ffb227579]Fludarabine phosphate [clinicaltrials_resource:9da3bebae8f3ae2f7a918fa17faaedde]Thiotepa [clinicaltrials_resource:b43b8e2083d58c79355bc0c6fc52a6e3]Allogeneic hematopoietic stem cell transplantation (HSCT) [clinicaltrials_resource:d7244d74c2a91dbef853b4215dda6aa1]clinicaltrials:NCT01760655
arm group [clinicaltrials_vocabulary:arm-group]
NCT01760655 arm group cd39c7e245762b84be1f2743b196e5c5 [clinicaltrials_resource:NCT01760655/arm-group/cd39c7e245762b84be1f2743b196e5c5]
Bio2RDF identifier
NCT01760655/arm-group/cd39c7e245762b84be1f2743b196e5c5
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 39c7e245762b84be1f2743b196e5c5
description [clinicaltrials_vocabulary:description]
REDUCED INTENSITY CONDITIONING ...... fetil IV BID on days -1 to 28.
identifier
clinicaltrials_resource:NCT01760655/arm-group/cd39c7e245762b84be1f2743b196e5c5
title
NCT01760655 arm group cd39c7e245762b84be1f2743b196e5c5
@en
type
label
NCT01760655 arm group cd39c7e2 ...... 9c7e245762b84be1f2743b196e5c5]
@en